Leonsis Theodore 4
4 · Tempus AI, Inc. · Filed May 26, 2026
Research Summary
AI-generated summary of this filing
Tempus AI (TEM) Director Theodore Leonsis Receives RSU Award
What Happened
- Theodore Leonsis, a director of Tempus AI, was granted 5,913 restricted stock units (RSUs) on May 21, 2026. The Form 4 reports an acquisition price of $0.00 for the award (i.e., no cash paid at grant). The filing shows the RSUs as an award/grant (transaction code A) rather than an open-market purchase or sale.
Key Details
- Transaction date: 2026-05-21; Form 4 filed: 2026-05-26 (filed five days after the grant date; Form 4s are typically due within two business days, so this appears later than usual).
- Shares/units granted: 5,913 RSUs; reported acquisition price: $0.00.
- Shares owned after transaction: not specified in the provided filing.
- Footnote: The RSUs vest in full on the earlier of (i) the issuer’s 2027 annual meeting of stockholders (or immediately prior if the director’s service ends at that meeting) or (ii) May 21, 2027, subject to the director’s continuous service through the applicable vesting date.
Context
- RSUs are a form of compensation that convert to shares only after vesting; they do not represent immediately tradable shares and require continued service to the company. This type of transaction is typically a compensation award for service and should not be interpreted as an open-market buy or sell signal. The reported $0 acquisition price reflects that this was an awarded grant, and the economic value will depend on TEM’s share price at vesting.
Insider Transaction Report
Form 4
Leonsis Theodore
Director
Transactions
- Award
Class A Comnmon Stock
[F1]2026-05-21+5,913→ 21,424 total
Holdings
- 66,756(indirect: By Trust)
Class A Common Stock
Footnotes (1)
- [F1]Represents a restricted stock unit ("RSU") award. The RSUs will vest in full on the earlier of (i) the date of the Issuer's 2027 annual meeting of the stockholders (or the date immediately prior to such annual meeting if the Reporting Person's service as a director ends at such annual meeting) or (ii) on May 21, 2027, each subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date.
Signature
/s/ Andrew Polovin, Attorney-in-Fact|2026-05-26